Good times ahead for pharma packaging
Your pharma packaging market in India is fast moving on the development ladder with several growth drivers like establishment of several small and huge product manufacturing and processing industries coming up at a larger scale. Moreover, since several pharma companies tend to be exporting their products on the overseas markets they may be adopting high degree packaging standards on par while using international standards. In an online interview, SV Krishna Prasad, BOSS & Director, Cito Professional medical (P) Ltd, sheds light for the growth prospects on the Indian packaging industry and shares information on various aspects associated with packaging with Amguth Raju.
How will you view the pharma appearance industry in India? Could you give your perspective in regards to the prospects of this packaging sector in the united states? Indian pharma packaging will assume a greater importance inside the times to occur, as we are having one of several world’s biggest and growing pharmaceutical industries consisting of huge packing/packaging needs for bulk drugs, formulations, diagnostic equipments/kits, clinical trial drug packaging specifically for multicentric trials both the investigational drug products along with the analyzable samples associated with plasma, serum for example.
How big industry size for pharma appearance globally is and where does India stand? As each 2011 statistics, this global market size for pharma appearance stood at $34 million. Currently the development of packaging industry in India is moving for a faster pace compared to that of this global sector. In line with Industry forecast simply by 2015, Indian pharma appearance sector is anticipated to be at $50 million
What according to you personally are the important growth drivers regarding pharma packaging? The major drivers attributing on the growth of appearance industry in India include the rise of numerous product processing products, among these foodstuff processing, formulations, bulk drugs and also other related industries include catalyzed the development of packaging market. Moreover many ones are adopting advanced packaging technology to be sure safety, quality and prolonged shelf life on the products. For case in pharmaceutical portion, nano-enabled packaging regarding blisters is widely used. This is planning to grow to $2. 10 billion with the end of 2014.
The pharmaceutical packaging market is constantly advancing and has experienced annual growth of at the least five per dime per annum previously few years. The market is now reckoned to get worth over $20 billion 1 year. As with most other packaged goods, pharmaceuticals need dependable and speedy appearance solutions that deliver a variety of product protection, excellent, tamper evidence, individual comfort and safety measures needs.
How does one view the pharma packaging sector inside the emerging markets? From the emerging markets, India, China and Brazil are fast catching up your of the standards people, Western Europe and Japanese markets. As huge quantities of pharmaceutical products are exported to this advanced countries via India, China and Brazil, it has grown to be imperative for this developing markets to follow the packaging standards on the advanced countries. Because the emerging markets are providing less expensive and standard appearance solutions, many overseas firms are outsourcing the business to nations around the world like India and china for less expensive solutions.
How does one view the responsibility of pharma firms in ensuring this safely packed products reach the finish users? It is high time that all pharma firms realize their responsibility how the packed products these people manufactured reach the finish users safely with no tampering. As most on the Indian pharma merchandise are exported to other countries you have to have adopted foolproof appearance technology. Even the middle government agencies may also be taking steps within ensuring better packing systems to get evolved.
In view associated with stringent regulations it's important pharma companies ensure product as well as packaging is qualitative and compliant, they must ensure safety of the item that is packed as well.
What is the existing estimate of pharma appearance sector in India and the amount of it what people mean about plastic and PVC appearance? The pharma packaging industry in the united states is estimated at around Rs 10, 000 crore. With this, plastics and PVC appearance market is pegged at all-around Rs 4000 crore.
The central govt has formed any panel to ban plastic containers for packaging pharma merchandise. How do people view this and what could possibly be the possible impact if ban comes into force? Over this years pharma firms have increasingly chosen plastic and FURRY FRIEND bottles over glass containers to offer cough syrups, antacids, vitamins as they're advantageous for
break proof, Light fat and reduce wastage On the other hand, banning would be appropriate on the extent that they end in leaching and carcinogenicity that's the major risks being envisioned used of plastic and PET media regarding pharma packaging. Banning is okay but an alternative like blister packs should be encouraged for cessation associated with plastic/PET usage over the pharma industry.
Additionally, as in the way it is of carry carriers regulated now, quality of this poly bag manufactured to your certain micron spec could be a win-win situation inside the sense that key research and expenditure in finding a new method is avoided, also as a cheaper alternative for example.
What precautions need to one take whilst packaging and just what could the possible implications of incorrect packaging? As pharma merchandise are highly reactive and involve life conserving chemicals utmost precautions should be taken as prescribed with the packaging manual for just a particular product. Improper packaging could produce many safety ramifications.
Impact could be such that an improper packaging could cause container loads associated with pharma materials getting stuck and be returned.